December 23, 2024
Science

Promising malaria vaccine candidate proves its worth in a Phase II trial with over 80% efficacy

<

You might also like

NASA’s DART Kinetic Impactor Spacecraft Launches in World’s First Planetary Defense Test Mission

New Study Reveals How a Common Laxative Improves Cognitive Function and Memory

Best Equipment for Aurora Photography

Blue Mussels & Water Pollution: Protecting Wales’s River Conwy